← All organizations

miRagen Therapeutics, Inc.

For profitWebsite ↗

Also known as: miRagen Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 31, 2019

Acquired by Viridian Therapeutics on Oct 15, 2020

Timeline

2000s

Jun 1, 2007
miRagen Therapeutics, Inc.— Founded

2010s

Feb 13, 2017
Signal Genetics— Acquired

2020s

Oct 15, 2020
Viridian Therapeutics— Acquired By

Drugs by trial phase (5 distinct, 6 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Signal Genetics

Recent trials (12)

NCT03837457Lead sponsorPhase 2Jul 31, 2019
NCT03837457Study directorPhase 2Jul 31, 2019
NCT03713320Study directorPhase 2Sep 12, 2018
NCT03713320Lead sponsorPhase 2Sep 12, 2018
NCT03601052Study directorPhase 2Jul 9, 2018
NCT03601052Lead sponsorPhase 2Jul 9, 2018
NCT03603431Lead sponsorPhase 1Apr 9, 2018
NCT03603431Study directorPhase 1Apr 9, 2018
NCT02603224Study directorPhase 1Nov 1, 2015
NCT02580552Lead sponsorPhase 1Nov 1, 2015
NCT02580552Study directorPhase 1Nov 1, 2015
NCT02603224Lead sponsorPhase 1Nov 1, 2015

Details

Founded: Boulder, CO, US Jun 1, 2007
Last known activity: Jul 31, 2019